License, Funding and Operational Agreement Sample Contracts

FIRST AMENDMENT TO LICENSE, FUNDING AND OPERATIONAL AGREEMENT

License, Funding and Operational Agreement • November 7th, 2022 • Curative Biotechnology Inc • Biological products, (no disgnostic substances)

• Contract Type
  License, Funding and Operational Agreement
• Filed
  November 7th, 2022
• Company
  Curative Biotechnology Inc
• Industry
  Biological products, (no disgnostic substances)

THIS IS THE FIRST AMENDMENT (the “Amendment”) to the License, Funding and Operational Agreement for rabies immunotherapy (the “Agreement”) between Mid-Atlantic BioTherapeutics, Inc. (“Licensor”) and Curative Biotechnology, Inc., formerly Connectyx, (“Licensee”) originally executed September 30th, 2020.